Contributions of Eosinophils to Human Health and Disease.
暂无分享,去创建一个
[1] R. Fitzgerald,et al. Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[2] A. Zwinderman,et al. Anti‐IL‐5 in Mild Asthma Alters Rhinovirus‐induced Macrophage, B‐Cell, and Neutrophil Responses (MATERIAL). A Placebo‐controlled, Double‐Blind Study , 2019, American journal of respiratory and critical care medicine.
[3] S. Fujieda,et al. Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis , 2019, Front. Immunol..
[4] Kelley E. Capocelli,et al. The 1‐Hour Esophageal String Test: A Non‐Endoscopic Minimally Invasive Test to Accurately Detect Disease Activity in Eosinophilic Esophagitis: 935 , 2019, Journal of Allergy and Clinical Immunology.
[5] V. Gaponenko,et al. Novel peptide nanoparticle–biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness , 2019, The Journal of allergy and clinical immunology.
[6] J. Brennan,et al. Rapid quantification of sputum eosinophil peroxidase on a lateral flow test strip , 2019, Allergy.
[7] W. Busse,et al. Anti–IL‐5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison , 2019, The Journal of allergy and clinical immunology.
[8] Ascp,et al. Siglec-8 in eosinophilic disorders: receptor expression and targeting using chimeric antibodies , 2019 .
[9] S. Fujieda,et al. Charcot-Leyden crystal formation is closely associated with eosinophil extracellular trap cell death. , 2018, Blood.
[10] J. Utikal,et al. Opposing roles of eosinophils in cancer , 2018, Cancer Immunology, Immunotherapy.
[11] P. Khoury,et al. Consultation for Elevated Blood Eosinophils: Clinical Presentations, High Value Diagnostic Tests, and Treatment Options. , 2018, The journal of allergy and clinical immunology. In practice.
[12] M. Fay,et al. Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome. , 2018, The journal of allergy and clinical immunology. In practice.
[13] P. Zeitlin,et al. Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial , 2018, Journal of asthma and allergy.
[14] M. Fay,et al. Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes. , 2018, Blood.
[15] A. Straumann,et al. Minimally invasive biomarker studies in eosinophilic esophagitis: A systematic review. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[16] C. Brightling,et al. In vivo imaging reveals increased eosinophil uptake in the lungs of obese asthmatic patients , 2018, The Journal of allergy and clinical immunology.
[17] I. Hirano,et al. Biological therapies for eosinophilic gastrointestinal diseases , 2018, The Journal of allergy and clinical immunology.
[18] P. Weller,et al. Contemporary understanding of the secretory granules in human eosinophils , 2018, Journal of leukocyte biology.
[19] H. Simon,et al. Revisiting the NIH Taskforce on the Research needs of Eosinophil‐Associated Diseases (RE‐TREAD) , 2018, Journal of leukocyte biology.
[20] James J. Lee,et al. Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease , 2018, Journal of leukocyte biology.
[21] K. Rabe,et al. Efficacy and Safety of Dupilumab in Glucocorticoid‐Dependent Severe Asthma , 2018, The New England journal of medicine.
[22] D. Allman,et al. No strict requirement for eosinophils for bone marrow plasma cell survival , 2018, European journal of immunology.
[23] H. Jäck,et al. Eosinophils are not essential for maintenance of murine plasma cells in the bone marrow , 2018, European journal of immunology.
[24] K. Bennett,et al. CEBPE-Mutant Specific Granule Deficiency Correlates With Aberrant Granule Organization and Substantial Proteome Alterations in Neutrophils , 2018, Front. Immunol..
[25] B. Bochner. The eosinophil: For better or worse, in sickness and in health. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[26] C. Bebbington,et al. A Randomized, Double-Blind, Placebo-Controlled, Ascending Dose Phase 1 Study of AK002, a Novel Siglec-8 Selective Monoclonal Antibody, in Healthy Subjects , 2018 .
[27] G. Marone,et al. Eosinophils: The unsung heroes in cancer? , 2018, Oncoimmunology.
[28] B. Chawes,et al. Efficacy, adverse events, and inter-drug comparison of mepolizumab and reslizumab anti-IL-5 treatments of severe asthma – a systematic review and meta-analysis , 2018, European clinical respiratory journal.
[29] P. Khoury,et al. Clinical and Biological Markers in Hypereosinophilic Syndromes , 2017, Front. Med..
[30] F. Antonicelli,et al. Biomarkers related to bullous pemphigoid activity and outcome , 2017, Experimental dermatology.
[31] P. Weller,et al. Functions of tissue-resident eosinophils , 2017, Nature Reviews Immunology.
[32] T. Myers,et al. Dysregulation of interleukin 5 expression in familial eosinophilia , 2017, Allergy.
[33] P. Fulkerson. Transcription Factors in Eosinophil Development and As Therapeutic Targets , 2017, Front. Med..
[34] I. Bachelet,et al. CD300f:IL-5 cross-talk inhibits adipose tissue eosinophil homing and subsequent IL-4 production , 2017, Scientific Reports.
[35] T. Marichal,et al. Homeostatic Eosinophils: Characteristics and Functions , 2017, Front. Med..
[36] A. Klion. Recent advances in understanding eosinophil biology , 2017, F1000Research.
[37] P. Thomas,et al. Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus , 2017, The Journal of Immunology.
[38] Sara R. Selitsky,et al. A Gene Expression Panel is Accurate for Diagnosis and Monitoring Treatment of Eosinophilic Esophagitis in Adults , 2017, Clinical and translational gastroenterology.
[39] C. Porsbjerg,et al. Clinical characteristics of eosinophilic asthma exacerbations , 2016, Respirology.
[40] J. Appleton,et al. Eosinophils in Helminth Infection: Defenders and Dupes. , 2016, Trends in parasitology.
[41] A. Ghaemmaghami,et al. Effective antigen presentation to helper T cells by human eosinophils , 2016, Immunology.
[42] W. Muller. Transendothelial migration: unifying principles from the endothelial perspective , 2016, Immunological reviews.
[43] J. Rinn,et al. The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan , 2016, Nature.
[44] W. Petri,et al. Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection. , 2016, Cell reports.
[45] M. Fay,et al. Clinical features predict responsiveness to imatinib in platelet‐derived growth factor receptor‐alpha‐negative hypereosinophilic syndrome , 2016, Allergy.
[46] M. Svensson-Frej,et al. Eosinophils may play regionally disparate roles in influencing IgA+ plasma cell numbers during large and small intestinal inflammation , 2016, BMC Immunology.
[47] D. Dorward,et al. Key mechanisms governing resolution of lung inflammation , 2016, Seminars in Immunopathology.
[48] M. Westphall,et al. The Peripheral Blood Eosinophil Proteome. , 2016, Journal of proteome research.
[49] P. Kuna,et al. Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma , 2016, BMJ Open.
[50] Shiori Yamamoto,et al. Eosinophil extracellular trap cell death-derived DNA traps: Their presence in secretions and functional attributes. , 2016, The Journal of allergy and clinical immunology.
[51] Manna Zhang,et al. Eosinophils Reduce Chronic Inflammation in Adipose Tissue by Secreting Th2 Cytokines and Promoting M2 Macrophages Polarization , 2015, International journal of endocrinology.
[52] B. Bochner. Novel Therapies for Eosinophilic Disorders. , 2015, Immunology and allergy clinics of North America.
[53] J. Woosley,et al. Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study , 2015, The American Journal of Gastroenterology.
[54] M. Raffeld,et al. Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder , 2015, Haematologica.
[55] R. Raskin,et al. Reptilian Eosinophils: Beauty and Diversity by Light Microscopy. , 2015, Veterinary clinical pathology.
[56] Eh Lee,et al. IL-1β in eosinophil-mediated small intestinal homeostasis and IgA production , 2014, Mucosal Immunology.
[57] M. Camilleri,et al. Accuracy, safety, and tolerability of tissue collection by Cytosponge vs endoscopy for evaluation of eosinophilic esophagitis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[58] Lisa J. Martin,et al. Food , drug , insect sting allergy , and anaphylaxis Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis , 2022 .
[59] T. Neri,et al. Genetic Susceptibility to ANCA-Associated Vasculitis: State of the Art , 2014, Front. Immunol..
[60] M. Telen,et al. Phase 1 Study of the E-Selectin Inhibitor GMI 1070 in Patients with Sickle Cell Anemia , 2014, PloS one.
[61] D. Broide,et al. Smad3-Deficient Mice Have Reduced Esophageal Fibrosis and Angiogenesis in a Model of Egg-Induced Eosinophilic Esophagitis , 2014, Journal of pediatric gastroenterology and nutrition.
[62] R. Palmiter,et al. Eosinophils and Type 2 Cytokine Signaling in Macrophages Orchestrate Development of Functional Beige Fat , 2014, Cell.
[63] K. Acharya,et al. Eosinophil Granule Proteins: Form and Function , 2014, The Journal of Biological Chemistry.
[64] M. Raffeld,et al. The eosinophil surface receptor epidermal growth factor-like module containing mucin-like hormone receptor 1 (EMR1): a novel therapeutic target for eosinophilic disorders. , 2014, The Journal of allergy and clinical immunology.
[65] C. Berek,et al. Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis. , 2014, Immunity.
[66] James J. Lee,et al. Eosinophils Regulate Peripheral B Cell Numbers in Both Mice and Humans , 2014, The Journal of Immunology.
[67] C. Persson,et al. Theirs but to die and do: primary lysis of eosinophils and free eosinophil granules in asthma. , 2014, American journal of respiratory and critical care medicine.
[68] James J. Lee,et al. PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS Activated mouse eosinophils protect against lethal respiratory virus infection , 2015 .
[69] E. Chilvers,et al. Measurement of eosinophil kinetics in healthy volunteers. , 2014, Methods in molecular biology.
[70] E. King,et al. Molecular diagnosis of eosinophilic esophagitis by gene expression profiling. , 2013, Gastroenterology.
[71] James J. Lee,et al. Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia , 2013, Allergy.
[72] James J. Lee,et al. PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS Expression of the secondary granule proteins major basic protein 1 ( MBP-1 ) and eosinophil peroxidase ( EPX ) is required for eosinophilopoiesis in mice , 2013 .
[73] James J. Lee,et al. The consequences of not having eosinophils , 2013, Allergy.
[74] John A. Besse,et al. Targeted Ablation of miR-21 Decreases Murine Eosinophil Progenitor Cell Growth , 2013, PloS one.
[75] R. Locksley,et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages , 2013, The Journal of experimental medicine.
[76] John A. Besse,et al. miR-223 Deficiency Increases Eosinophil Progenitor Proliferation , 2013, The Journal of Immunology.
[77] K. Dyer,et al. Eosinophils: changing perspectives in health and disease , 2012, Nature Reviews Immunology.
[78] James J. Lee,et al. Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red". , 2012, The Journal of allergy and clinical immunology.
[79] W. Busse,et al. Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD). , 2012, The Journal of allergy and clinical immunology.
[80] T. Haferlach,et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. , 2012, The Journal of allergy and clinical immunology.
[81] D. Fleischer,et al. The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis , 2012, Gut.
[82] N. Bhattacharyya,et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. , 2012, Blood.
[83] S. Wenzel,et al. Asthma outcomes: biomarkers. , 2012, The Journal of allergy and clinical immunology.
[84] M. Fay,et al. IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis. , 2011, The Journal of allergy and clinical immunology.
[85] A. Varki,et al. Siglec-F Inhibition Reduces Esophageal Eosinophilia and Angiogenesis in a Mouse Model of Eosinophilic Esophagitis , 2011, Journal of pediatric gastroenterology and nutrition.
[86] R. Locksley,et al. Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis , 2011, Science.
[87] C. Berek,et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow , 2011, Nature Immunology.
[88] D. Traver,et al. Eosinophils in the zebrafish: prospective isolation, characterization, and eosinophilia induction by helminth determinants. , 2010, Blood.
[89] W. Busse,et al. Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma. , 2010, The Journal of allergy and clinical immunology.
[90] O. Yang,et al. Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence. , 2010, Clinical immunology.
[91] James J. Lee,et al. Eosinophils in health and disease: the LIAR hypothesis , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[92] J. Sheikh,et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. , 2009, The Journal of allergy and clinical immunology.
[93] R. Egan,et al. The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti-α4β7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases , 2009, Journal of Pharmacology and Experimental Therapeutics.
[94] L. Kremer,et al. TLR2-dependent eosinophil interactions with mycobacteria: role of alpha-defensins. , 2009, Blood.
[95] K. Akashi,et al. Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor , 2009, The Journal of experimental medicine.
[96] A. Sharma,et al. Human C/EBP-epsilon activator and repressor isoforms differentially reprogram myeloid lineage commitment and differentiation. , 2009, Blood.
[97] A. Straumann,et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense , 2008, Nature Medicine.
[98] D. Broide,et al. Airway fibrosis and angiogenesis due to eosinophil trafficking in chronic asthma. , 2008, Current molecular medicine.
[99] J. Parkin,et al. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. , 2008, The New England journal of medicine.
[100] I. Ghiran,et al. Airway Eosinophils: Allergic Inflammation Recruited Professional Antigen-Presenting Cells1 , 2007, The Journal of Immunology.
[101] S. Gordon,et al. EMR1, the human homolog of F4/80, is an eosinophil‐specific receptor , 2007, European journal of immunology.
[102] M. Goldman,et al. Lymphocytic variant hypereosinophilic syndromes. , 2007, Immunology and allergy clinics of North America.
[103] R. Weiss,et al. EGO, a novel, noncoding RNA gene, regulates eosinophil granule protein transcript expression. , 2007, Blood.
[104] S. Phipps,et al. Eosinophil trafficking in allergy and asthma. , 2007, The Journal of allergy and clinical immunology.
[105] Mitchell Cohen,et al. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[106] B. Aronow,et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. , 2006, The Journal of clinical investigation.
[107] J. Varga,et al. Eosinophil-fibroblast interactions induce fibroblast IL-6 secretion and extracellular matrix gene expression: implications in fibrogenesis. , 2005, The Journal of allergy and clinical immunology.
[108] E. Lenkiewicz,et al. Defining a Link with Asthma in Mice Congenitally Deficient in Eosinophils , 2004, Science.
[109] D. Metcalfe,et al. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. , 2004, Blood.
[110] D. Gilliland,et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. , 2003, Blood.
[111] David H. Miller,et al. A controlled trial of natalizumab for relapsing multiple sclerosis. , 2003, The New England journal of medicine.
[112] Jonathan E. Schmitz,et al. Novel Combinatorial Interactions of GATA-1, PU.1, and C/EBPε Isoforms Regulate Transcription of the Gene Encoding Eosinophil Granule Major Basic Protein* , 2002, The Journal of Biological Chemistry.
[113] P. Schmid‐Grendelmeier,et al. High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome. , 2002, The Journal of allergy and clinical immunology.
[114] A. Iwama,et al. Essential and Instructive Roles of GATA Factors in Eosinophil Development , 2002, The Journal of experimental medicine.
[115] S. Orkin,et al. Targeted Deletion of a High-Affinity GATA-binding Site in the GATA-1 Promoter Leads to Selective Loss of the Eosinophil Lineage In Vivo , 2002, The Journal of experimental medicine.
[116] T. Graf,et al. Making Eosinophils Through Subtle Shifts in Transcription Factor Expression , 2002, The Journal of experimental medicine.
[117] Lin Ying Liu,et al. Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge. , 2002, Journal of immunology.
[118] L. Sturla,et al. Impairment of the Golgi GDP-l-Fucose Transport and Unresponsiveness to Fucose Replacement Therapy in LAD II Patients , 2001, Pediatric Research.
[119] J. Erjefält,et al. Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation. , 2001, American journal of respiratory cell and molecular biology.
[120] B. Bochner. Road signs guiding leukocytes along the inflammation superhighway. , 2000, The Journal of allergy and clinical immunology.
[121] F. Symon,et al. Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow. , 2000, Blood.
[122] Jianzhi Zhang,et al. Evolution of the rodent eosinophil-associated RNase gene family by rapid gene sorting and positive selection. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[123] D. Friend,et al. Eotaxin is required for the baseline level of tissue eosinophils. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[124] C. Barlow,et al. CCAAT/enhancer binding proteins are critical components of the transcriptional regulation of hematopoiesis (Review). , 1998, International journal of molecular medicine.
[125] P. Foster,et al. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model , 1996, The Journal of experimental medicine.
[126] P. Hodgkin,et al. IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. , 1996, Immunity.
[127] R. Steigbigel,et al. Eosinophilia in patients infected with human immunodeficiency virus. , 1996, The Journal of infectious diseases.
[128] F. Symon,et al. Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent , 1994, The Journal of experimental medicine.
[129] M. Blaser,et al. Disseminated coccidioidomycosis associated with extreme eosinophilia. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[130] H. Rosenberg,et al. Neutrophil-specific granule deficiency includes eosinophils. , 1993, Blood.
[131] D. Wong,et al. Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. , 1993, Journal of immunology.
[132] P. Spessotto,et al. Eosinophil peroxidase deficiency: morphological and immunocytochemical studies of the eosinophil-specific granules. , 1992, Blood.
[133] G. Gleich,et al. Sequestration of eosinophil major basic protein in human mast cells. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[134] D. Boggs,et al. Search for eosinopenia in hospitalized patients with normal blood leukocyte concentration , 1987, American journal of hematology.
[135] T. Springer,et al. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. , 1987, Annual review of medicine.
[136] U. Blumenthal,et al. Eosinophilia and resistance to Schistosoma haematobium in man , 1985, Parasite immunology.
[137] H. Sampson,et al. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. , 1985, The New England journal of medicine.
[138] G. Gleich,et al. Deposition of eosinophil granule major basic protein onto microfilariae of Onchocerca volvulus in the skin of patients treated with diethylcarbamazine. , 1984, Laboratory investigation; a journal of technical methods and pathology.